The United States biocatalyst market size reached US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.1 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 3.4 Billion |
Market Forecast in 2032
|
US$ 6.1 Billion |
Market Growth Rate (2024-2032) | 6.5% |
Biocatalyst refers to the enzyme present in living organisms, including plants, animals and microorganisms, that helps in modifying the rate of several chemical reactions and conversion of organic compounds. Generally, they are biodegradable, organic and possess superior catalytic efficiency. Apart from this, they are also utilized in the pharmaceutical industry for manufacturing numerous medicines, such as statins, amino acids and vitamins.
The market in the United States is primarily driven by significant growth in the field of biotechnology. Along with this, several major players are actively engaging in the manufacturing of artificial enzymes to promote proper body functioning. Moreover, numerous firms across the country are heavily investing to expand their manufacturing capabilities, which is also providing an impetus to the market growth. Some of the other factors contributing to the market growth include technological advancements in molecular engineering and extensive research and development (R&D) activities conducted by key players to introduce innovative biocatalyst technology.
IMARC Group provides an analysis of the key trends in each sub-segment of the United States biocatalyst market report, along with forecasts at the country and regional levels from 2024-2032. Our report has categorized the market based on type, application and source.
Breakup by Type:
Breakup by Application:
Breakup by Source:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Report Features | Details |
---|---|
Base Year of the Analysis | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Units | US$ Billion |
Segment Coverage | Type, Application, Source, Region |
Region Covered | Northeast, Midwest, South, West |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 3699 Five User License: US$ 4699 Corporate License: US$ 5699 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The United States biocatalyst market was valued at US$ 3.4 Billion in 2023.
We expect the United States biocatalyst market to exhibit a CAGR of 6.5% during 2024-2032.
The sudden outbreak of the COVID-19 pandemic had led to the implementation of stringent lockdown regulations across the nation resulting in the temporary closure of numerous end-use industries for biocatalysts.
The rising demand for biocatalyst in the production of biofuels and biopharmaceuticals, owing to the growing awareness regarding its environment sustainability, is primarily driving the global biocatalyst market.
Based on the type, the United States biocatalyst market can be segmented into hydrolases, oxidoreductases, transferases, and others. Currently, hydrolases hold the majority of the total market share.
Based on the application, the United States biocatalyst market has been divided into food and beverage, cleaning agents, biofuel production, agriculture and feed, biopharmaceuticals, and others. Among these, food and beverage currently exhibits a clear dominance in the market.
Based on the source, the United States biocatalyst market can be categorized into microorganisms, plants, and animal. Currently, microorganisms account for the largest market share.
On a regional level, the market has been classified into Northeast, Midwest, South, and West, where South currently dominates the United States biocatalyst market.